Oppenheimer & CO Inc Tyra Biosciences, Inc. Transaction History
Oppenheimer & CO Inc
- $6.52 Billion
- Q4 2024
A detailed history of Oppenheimer & CO Inc transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 75,439 shares of TYRA stock, worth $883,390. This represents 0.02% of its overall portfolio holdings.
Number of Shares
75,439
Previous 76,806
1.78%
Holding current value
$883,390
Previous $1.81 Million
41.94%
% of portfolio
0.02%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding TYRA
# of Institutions
112Shares Held
43.1MCall Options Held
3.8KPut Options Held
6K-
Ra Capital Management, L.P. Boston, MA10.6MShares$125 Million2.39% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$48.9 Million97.27% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$47.8 Million89.47% of portfolio
-
Nextech Invest Ag4.06MShares$47.5 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$46.2 Million2.05% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $492M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...